Last close As at 05/08/2026
GBP8.68
▲ 0.09 (0.01%)
Market capitalisation
—
Research: Industrials
Renewi offers one of the few ways to invest in the circular economy and recycling agenda, as highlighted by Macquarie’s recent interest. The reversal of recent strong recyclate pricing and a softer construction sector in the Netherlands has affected the recovery. Profits are still significantly ahead of pre-COVID levels with much of the recovery (eg Mineralz) and the full potential of the capex programme still to come, and to be followed by the drive to achieve management’s mid-term financial targets.
Renewi |
Recycling 2.0 |
Interim results |
Industrial support services |
13 November 2023 |
Share price performance
Business description
Next events
Analyst
Renewi is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||||||
Renewi offers one of the few ways to invest in the circular economy and recycling agenda, as highlighted by Macquarie’s recent interest. The reversal of recent strong recyclate pricing and a softer construction sector in the Netherlands has affected the recovery. Profits are still significantly ahead of pre-COVID levels with much of the recovery (eg Mineralz) and the full potential of the capex programme still to come, and to be followed by the drive to achieve management’s mid-term financial targets.
Year end |
Revenue (€m) |
PBT* |
EPS* |
DPS |
P/E |
Yield |
03/22 |
1,869 |
105.3 |
98.0 |
0.0 |
6.7 |
N/A |
03/23 |
1,892 |
103.7 |
90.0 |
0.0 |
7.3 |
N/A |
03/24e |
1,914 |
85.9 |
75.0 |
5.0 |
8.8 |
0.8 |
03/25e |
1,964 |
101.4 |
88.0 |
10.0 |
7.4 |
1.5 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
H124 results
Sales declined 2% in H124, primarily due to lower volumes, particularly Commercial Waste Netherlands in the construction & demolition (C&D) sector along with lower recyclate prices and some timing delays in the Water business. Operating margins declined from 7.9% in H123 to 5.4%, leading to underlying EBIT from €75.2m to €50.7m. Net finance costs increased to €19.8m and associates income to €0.4m, leaving underlying PBT of €31.3m. Underlying EPS declined from 56c to 27c. Core net debt was broadly stable at €383m with core net debt/EBITDA of 2.1x. The outlook is more positive, including benefits from further cost actions (€15m annualised savings), full benefits from recent plant expansions and Mineralz & Water volume improvement.
Capital market targets
The capital markets event in October provided medium-term targets along with greater detail on the underlying drivers (see Edison’s note A circular economy champion). The key targets are for at least 5% organic sales growth, high single-digit operating margins, free cash flow generation of at least 40% of EBITDA and a return on capital (ROCE) of over 15%. Our review of peers suggests that the first two should be achievable, while cash generation is likely to depend on the exceptional cash expenses. Our focus will be on ROCE, a key determinate of management custody of resources and encouragingly a component of management’s LTIP.
Forecasts and valuation
We have updated our forecasts to take into account the weaker performance in the Commercial Waste Netherlands business along with a slightly higher tax rate and minorities. We have reduced FY24 PBT from €92m to €86m and EPS from 81c to 75c, and FY25 PBT from €104m to 101m and EPS from 92c to 88c. We have reduced our FY24 core net debt expectation from €429m to €406m. Our core DCF valuation reduces marginally from 825p to 819p. Our peer-based valuation has reduced from 724p to 680p due to lower short-term profit expectations and recent stock market weakness.
Interim results
Sales declined 2% in H124, primarily due to lower volumes, particularly in some Commercial Waste sectors such as C&D along with lower recyclate prices. Operating margins declined from 7.9% in H123 to 5.4%, albeit H123 was supported by strong recyclate pricing suggesting the 6.1% in H223 may be a more realistic comparator. Exceptionals were positive driven by changes to the discount rates used for the UK Municipal provisions. Cash flow was controlled, highlighted by a working capital inflow of €5m. Core net debt increased marginally to €383m and the group retains facilities of €705m. Core net debt/EBITDA increased to 2.1x due to lower EBITDA.
Exhibit 1: Summary financial performance (€m)
H123 |
H223 |
H124 |
|
Turnover |
952.0 |
940.3 |
937.1 |
Operating margin |
7.9% |
6.1% |
5.4% |
Underlying EBIT |
75.2 |
57.7 |
50.7 |
Exceptionals |
10.0 |
(20.6) |
14.8 |
Reported EBIT |
85.2 |
37.1 |
65.9 |
Finance costs |
(12.0) |
(16.3) |
(19.8) |
Associates |
0.4 |
||
PBT reported |
71.6 |
21.5 |
45.4 |
PBT before exceptionals |
61.6 |
42.1 |
31.3 |
Underlying EPS (c) |
56 |
35 |
27 |
Underlying net cash/(debt) |
(388) |
(371) |
(383) |
Total net cash/(debt) |
(696) |
(695) |
(688) |
Core net debt/EBITDA |
1.7x |
1.8x |
2.1x |
Source: Renewi
Commercial Waste division
Exhibit 2: Commercial Waste division (€m)
H121 |
H221 |
H122 |
H222 |
H123 |
H223 |
H124 |
||
Netherlands |
Sales |
396.8 |
431.6 |
442.3 |
453.9 |
459.3 |
472.7 |
457.3 |
Operating margin |
5.3% |
7.6% |
9.8% |
11.0% |
8.8% |
7.7% |
5.6% |
|
Operating profit |
21.1 |
32.6 |
43.2 |
49.9 |
40.3 |
36.6 |
25.8 |
|
Belgium |
Sales |
198.5 |
214.4 |
228.9 |
238.0 |
235.1 |
233.3 |
237.5 |
Operating margin |
4.2% |
6.9% |
9.4% |
8.9% |
12.0% |
10.4% |
10.3% |
|
Operating profit |
8.3 |
14.8 |
21.5 |
21.1 |
28.1 |
24.3 |
24.5 |
|
Division |
Inbound |
510.1 |
522.1 |
535.6 |
537.4 |
538.4 |
551.2 |
562.2 |
Outbound |
53.9 |
76.5 |
97.8 |
114.4 |
115.3 |
102.7 |
87.1 |
|
On-site |
18.2 |
23.1 |
25.7 |
27.4 |
31.6 |
32.0 |
32.3 |
|
Other |
12.8 |
23.9 |
11.5 |
10.7 |
9.1 |
17.0 |
11.7 |
|
Turnover |
595.0 |
645.6 |
670.6 |
689.9 |
694.4 |
702.9 |
693.3 |
|
Operating margin |
4.9% |
7.3% |
9.6% |
10.3% |
9.9% |
8.7% |
7.3% |
|
Operating profit |
29.4 |
47.4 |
64.7 |
71.0 |
68.4 |
60.9 |
50.3 |
Source: Renewi
The top line of the Commercial Waste division was stable as price increases offset lower volumes and recyclate pricing. Profitability declined due to market softness and time lags in price increases implemented to offset cost inflation. Two key elements of note were:
■
Recyclate prices weakened by an average of c 20%. This is evidenced in the ‘Outbound’ revenue line declining from €115m in H123 to €87m. Ferrous, paper and plastic pricing has returned towards long-term levels although wood remains high. While management looks to offset recyclate price volatility through price pass-through agreements, the remaining, effectively unhedged, recyclates have had a significant impact on profitability.
■
Reduced C&D activity in the Netherlands due to economic weakness and pressure on nitrogen emissions, where the government is looking to reduce emissions in the construction sector by 60% by 2030, promoting a shift to electrification with a €42m subsidy fund, is providing a temporary hiatus. The softer market is highlighted in the reduced value of building starts being seen.
|
Exhibit 3: Netherlands building projects started (€m) |
|
|
Source: Centraal Bureau voor de Statistiek |
Mineralz & Water division
The performance of the Mineralz & Water (M&W) division was affected by lower volumes in ATM and planned maintenance pulled forward. Activity improved in Q2 with a positive H2 expected. The Mineralz business has contracts signed for 450ktpa, which underpin management expectation of a €5m profit uptick in the second half.
Exhibit 4: M&W division performance (€m)
H121 |
H221 |
H122 |
H222 |
H123 |
H223 |
H124 |
|
Sales |
90.4 |
92.4 |
93.6 |
100.3 |
93.3 |
97.6 |
88.4 |
Operating margin |
2.5% |
-2.2% |
4.3% |
1.8% |
2.8% |
-2.2% |
1.7% |
Operating profit |
2.3 |
(2.0) |
4.0 |
1.8 |
2.6 |
(2.1) |
1.5 |
Source: Renewi
Specialities division
Key to the Specialities division were the solid performances from Coolrec (electronic and electrical equipment waste) and Maltha (glass waste) despite the impact of lower recyclate pricing on margins. The UK municipal businesses’ performances remains weak and cash consumptive, with the operations still subject to the current review.
Exhibit 5: Specialities division performance (€m)
Division |
Coolrec & Maltha |
UK |
||||
H123 |
H124 |
H123 |
H124 |
H123 |
H124 |
|
Sales |
186.3 |
178.7 |
76.3 |
85.9 |
110.0 |
92.8 |
Operating margin |
6.1% |
5.8% |
10.9% |
9.9% |
2.7% |
1.9% |
Operating profit |
11.3 |
10.3 |
8.3 |
8.5 |
3.0 |
1.8 |
Source: Renewi
Exceptional charges
The exceptional costs were significantly reduced in the period. The change in provisions reflect the changes to discount rates. The amortisation of acquired intangibles has increased due to the Westpoort acquisition made in 2022.
Exhibit 6: Exceptional operating profit items
Item |
€m |
Renewi 2.0 improvement programme |
(1.0) |
Portfolio management activity |
0.3 |
Changes in long-term provisions |
17.1 |
Ineffectiveness and impact of termination of cash flow hedges |
0.7 |
Amortisation of acquisition related intangibles |
(3.0) |
Non-trading and exceptional items in PBT |
14.1 |
Item |
Renewi 2.0 improvement programme |
Portfolio management activity |
Changes in long-term provisions |
Ineffectiveness and impact of termination of cash flow hedges |
Amortisation of acquisition related intangibles |
Non-trading and exceptional items in PBT |
€m |
(1.0) |
0.3 |
17.1 |
0.7 |
(3.0) |
14.1 |
Source: Renewi
Cash flow and financial position
Net debt rose marginally due to the legacy issues and investment in growth capex. Management is guiding to an outflow of €30–35m for the full year, suggesting a slightly higher outflow in H2, which we would expect to include the c €5m cost of the additional restructuring programme and we have assumed no further working capital improvements.
|
Exhibit 7: Cash flow profile |
|
|
Source: Renewi |
Outlook
Management guidance for the full year is unchanged from the comment made in the October update: ‘Current and ongoing demand conditions expected to be largely offset by the increasing contribution from cost actions, meaning the Group’s full year performance is expected to be broadly in line with the Board’s expectations’.
Commercial Waste Belgium will fully benefit from the new site at Ghent to support the latest Vlarema 8 legislation. Commercial Waste Netherlands will benefit from the Acht site development but is expected to see continued softness in the C&D business but margin improvement from cost cutting (€15m group annual savings are targeted primarily in Commercial Waste Netherlands starting December 2023), pricing and operational improvements. The division will also see the benefit, or lack of headwind, from falling recyclate prices, which appear to have stabilised. M&W will see significant improvement as ATM volumes increase and Mineralz throughput increases.
Forecasts
We have updated our forecasts to take into account the weaker performance than we had anticipated in the Commercial Waste Netherlands business along with a slightly higher tax rate and minorities. Clearly there is risk on the timing of the cost savings programme and the expected improvement in M&W volumes. A full financial summary can be found on page 12.
Exhibit 8: Forecast changes
FY24e |
FY25e |
|||||
€m |
Old |
New |
Change |
Old |
New |
Change |
Revenues |
1,925 |
1,914 |
-0.6% |
2,007 |
1,964 |
-2.1% |
Normalised operating profit |
129 |
125 |
-3.6% |
147 |
144 |
-2.0% |
Normalised operating profit margin |
6.7% |
6.5% |
-0.2% |
7.3% |
7.3% |
0.0% |
Normalised PBT |
92 |
86 |
-7.0% |
104 |
101 |
-2.6% |
Reported PBT |
82 |
75 |
-8.0% |
98 |
95 |
-2.7% |
Normalised basic EPS (c) |
81 |
75 |
-8.0% |
92 |
88 |
-4.0% |
Dividend per share (c) |
5 |
5 |
0.0% |
10 |
10 |
0.0% |
Closing core net debt/(cash) |
429 |
406 |
-5.2% |
441 |
421 |
-4.4% |
Source: Edison Investment Research
Capital markets day
The recent capital markets event confirmed many of the positive trends for recycling highlighted in our preview note. Arguably the most interesting aspect was the medium-term financial targets management provided, highlighted in Exhibit 9. This section focuses on the achievability of these goals.
|
Exhibit 9: Key management targets |
|
|
Source: Renewi. Note: *Cash flow before dividends, growth projects and M&A. **FY23 revenue growth including Westpoort acquisition. |
Underlying EBIT margin
Exhibit 10 highlights management’s roadmap for margin expansion.
|
Exhibit 10: Company margin roadmap |
|
|
Source: Renewi |
Recyclate prices have been volatile and were particularly beneficial in FY22 and Q123. Hence the correct starting point is arguably best reflected in the H223 margin of 6.1%. Below we consider the major steps in a little more detail.
Digitisation and SG&A savings
The Renewi 2.0 programme has been completed with €20m of savings being generated (€17.8m in FY23). The digitisation programme is expected to generate further internal operational benefits while management initiates additional cost actions. Overall, management has targeted internal savings of €15m a year, which would add 90bp to operating margins.
UK Muni solved
Exiting will reduce revenue by c €200m and assuming 2% operating margin, we estimate this would add 70bp to operating margins.
Recycling rate & quality
Investment to increase the percentage of recycling (target from 63.6% to 75%) and the quality of recyclates should boost returns. Increasing recycling reduces incineration costs as Renewi does not own any such facilities; we note that ‘cost of waste’ accounted for 36% of the cost base in FY23. Higher-quality recyclates not only improve pricing but also assist in moving away from the commodity pricing fluctuations.
Growth
Investment is being targeted in areas that promote recycling and recyclate quality. The €60m investment in advanced recycling at Ghent, Puurs and Limberg provides the clearest example. Recent Vlarema 8 legislation in Flanders requires companies to increase the level of waste sorting and recycling, with up to 24 different waste streams to be identified with significant penalties for non-compliance. This should lead to more waste being diverted away from incineration/landfill and additional processing, adding value to the stream and profitability to Renewi.
M&W recovery
Key is the soil remediation business, which has been loss making but historically generated over 10% margins. Management is looking to double throughput with contracts for a 50% increase to 450kt already in place. This will provide greater overhead recovery while the move to higher-value products (sand, gravel and filler) should also assist in turning around the fortunes of ATM. 10% ROS would add c €20m to EBIT and improve group margins by c 100bp.
Headwinds
On the negative front, there will clearly be challenges from inflationary pressures, which management will aim to pass through via pricing along with the inevitable ebbs and flows of recyclate pricing, as seen in FY23.
Overall
Our analysis suggests that the benefits from digitisation/SG&A, UK Muni resolution and M&W recovery, which we have also separated out, would achieve the targeted margin improvement. This leaves additional potential from the growth and recycling initiatives depending on the ability to offset the current inflationary headwinds. Peer group analysis has limitations due to the differing business models, but Exhibit 11 shows the potential for best in class, which is clearly management’s goal.
Exhibit 11: Peer group underlying operating margins
2021/22 |
2022/23 |
|
Befesa |
18.1% |
11.3% |
Groupe Pizzorno |
9.7% |
6.0% |
Lassila & Tikanoja |
5.7% |
4.9% |
Seche |
8.6% |
9.3% |
Veolia |
6.2% |
7.2% |
Average |
9.7% |
7.7% |
Median |
8.6% |
7.2% |
Renewi |
7.0% |
6.3% |
Source: Company reports, Edison Investment Research
Organic growth
Exhibit 12 highlights the group’s recent growth profile including the impact from COVID-19 in FY21 and recyclate pricing in FY22. Management’s plan for 5% organic revenue growth compares to the 3% seen over the last five years.
|
Exhibit 12: Organic sales growth |
|
|
Source: Renewi, Edison Investment Research |
Management set out some clear targeted avenues for expansion, which are being backed by significant capex (€30.8m in FY23 and expected to be €50m in FY24).
Exhibit 13: Key growth drivers
Activity |
Revenue growth potential (€m) |
Key driver |
Construction & demolition |
50 |
Market set to recover after slowdown 2022–24. Growth from partnerships and higher-value recycling options from innovations |
Glass |
40 |
Regulation, eg European target to boost collection for recycling from 79% (2020) to 90% by 2030, along with innovation, eg solar panel recycling and geographic expansion |
Organics |
100 |
Upscaling from incineration/composting to primary products such as fibreboard |
Plastics |
35 |
Demand for recyclate in Europe to double driven by consumer company sustainability drive |
Zero waste solutions |
50 |
Emerging market as companies look to address their waste/sustainability targets, eg recent contract with Schiphol airport |
Total |
275 |
Source: Renewi
The €275m revenue growth potential would translate to only c 3% annual growth. This is similar to the historical growth rate of 3% over a five-year period when the focus was on internal operational performance and margin improvements, suggesting a positive underlying market clearly exists, which should also assist. Current inflation pricing trends are also likely to promote the top line. It is also worth reviewing the growth being achieved by Renewi’s European peers, clearly above the 5% management target.
Exhibit 14: Peer organic growth
2021 |
2022 |
H1 2023 |
|
Groupe Pizzorno |
6.5% |
8.9% |
18.7% |
Lassila & Tikanoja |
6.6% |
6.4% |
1.6% |
Seche |
9.4% |
14.4% |
8.5% |
Veolia (waste operations) |
11.8% |
6.8% |
3.3% |
Average |
8.6% |
9.1% |
8.0% |
Median |
8.0% |
7.9% |
5.9% |
Source: Edison Investment Research
Cash generation
Management is targeting operational free cash generation, which includes maintenance capex but excludes growth orientated capex, equal to 40% of EBITDA against 10% seen in FY23. Our analysis in Exhibit 15 assumes five years as ‘medium term’ and incorporating the operating targets suggests this is achievable, provided the legacy liabilities (UK Muni, ATM and COVID tax) are all resolved and the medium-term margin targets are achieved. Note that overall cash generation will be restricted due to growth capex (€30.8m in FY23 and expected to be €50m in FY24 with plan to invest c 30% of free cash flow) and the announced plan to recommence paying dividend (3-4x cover suggests a €40m annual cash cost in the medium-term scenario).
Exhibit 15: Operational cash generation (€m)
FY23 |
Medium term |
Comment |
|
Revenue |
1,892 |
2,200 |
|
Operating margin |
9.0% |
In line with management targets |
|
EBIT |
133 |
198 |
|
Depreciation |
124 |
135 |
|
EBITDA |
257 |
333 |
|
Maintenance capex inc leases |
(135) |
(135) |
Maintenance capex=depreciation |
Working capital |
(24) |
(6) |
10% of annual sales growth |
Share scheme charges |
3 |
3 |
|
Pension cash top-up |
(4) |
(3) |
|
Provision (ATM, UK Muni, COVID tax) |
(33) |
||
Restructuring/other |
3 |
||
Interest |
(21) |
(23) |
|
Tax |
(21) |
(40) |
27% cash tax rate |
Operational free cash |
25 |
129 |
|
Operational free cash to EBITDA |
10% |
39% |
Source: Edison Investment Research
ROCE
The company is targeting >15% ROCE, up from 10.6% reported in FY23, suggesting c 5% improvement. Our analysis uses a slightly different return on capital formula (underlying EBIT to total assets less current liabilities), which produces a slightly lower figure. As Exhibit 16 highlights, Renewi’s performance is not out of line with peers.
Exhibit 16: Peer ROCE
Dec 21/Mar 22 |
Dec 22/Mar 23 |
|
Befesa |
10.5% |
10.5% |
Groupe Pizzorno |
11.8% |
7.7% |
Lassila & Tikanoja |
10.2% |
9.7% |
Seche |
8.4% |
9.7% |
Veolia |
6.2% |
8.3% |
Average |
9.4% |
9.2% |
Median |
10.2% |
9.7% |
Renewi |
11.0% |
9.4% |
Source: Edison Investment Research
Going forward, margin expansion will assist as will the commercialisation of the investment capex. The impact of any exit of the UK Muni businesses, particularly on the balance sheet, is unclear at present. Hence, we see improvement potential but also see 15% ROCE as the hardest target for management to achieve.
Summary
There are clear positive market fundamentals at both the European level (eg the European Green Deal) and the local level (eg Flanders’ Vlarema 8 advanced waste sorting requirements). Combined with the expansionary capex, we see the 5% growth target as achievable, as peers are also reporting. Much of the expansion will be in higher-value sorting, recyclates and services, which, along with the internal actions, should boost returns. The key will be ROCE to ensure that management is generating real value. Here, we note that ROCE accounts for 25% of management’s LTIP, suggesting positive alignment and incentive.
UK municipal operations
Management has initiated a review of the UK municipal operations. Exhibit 17 highlights the continued cash consumption from these activities. Hence an exit would be positive for both ongoing financials and, we would expect, for investor sentiment.
Exhibit 17: Private finance initiative portfolio
Contract |
Financial close |
Full service commitment |
Contract expiry |
Interests in special purpose vehicle |
Argyll & Bute |
September 2001 |
April 2003 |
September 2026 |
100% |
Cumbria |
June 2009 |
April 2013 |
June 2034 |
100% |
Wakefield |
January 2013 |
December 2015 |
February 2038 |
50.001% |
Barnsley, Doncaster and Rotherham |
March 2012 |
July 2015 |
June 2040 |
100% |
East London Waste Authority |
December 2002 |
August 2007 |
December 2027 |
20% |
Source: Renewi
|
Exhibit 18: UK private finance initiative cash spend |
|
|
Source: Renewi |
Valuation
Our note A circular economy champion contained a detailed valuation and methodology; an update for the key discounted cash flow (DCF) and peer group valuations is provided below. Exhibit 19 highlights our new valuation and changes, incorporating our revised forecasts. Based on short-term profitability metrics (FY24 and FY25) and softening peer stock prices, the peer group based valuation sees the greatest impact. Our longer-term orientated DCF valuation remains virtually unchanged.
Exhibit 19: Valuation changes (pence per share)
Old |
New |
Change |
|
DCF |
825 |
819 |
-0.7% |
Peer group |
724 |
680 |
-6.1% |
Take-out |
1,238 |
1,207 |
-2.5% |
Source: Edison Investment Research
Exhibit 20: DCF valuation sensitivity (pence per share)
Terminal growth rate |
|||||
WACC |
1.0% |
2.0% |
3.0% |
4.0% |
5.0% |
12.0% |
331 |
380 |
439 |
514 |
610 |
11.5% |
392 |
449 |
518 |
606 |
722 |
11.0% |
460 |
525 |
607 |
712 |
852 |
10.5% |
535 |
611 |
708 |
834 |
1,006 |
10.0% |
619 |
709 |
823 |
977 |
1,191 |
9.5% |
713 |
819 |
957 |
1,145 |
1,418 |
9.0% |
819 |
945 |
1,113 |
1,348 |
1,701 |
8.5% |
940 |
1,092 |
1,298 |
1,596 |
2,065 |
8.0% |
1,079 |
1,263 |
1,521 |
1,907 |
2,552 |
7.5% |
1,239 |
1,466 |
1,793 |
2,307 |
3,233 |
Source: Edison Investment Research
Exhibit 21: Quoted peer group valuation
2023 |
2024 |
2023 |
2024 |
2023 |
2024 |
|
Applied multiple |
EV/EBIT |
EV/EBITDA |
P/E |
|||
Peer group rating (x) |
13.6 |
11 |
6.3 |
5.7 |
17.2 |
14.2 |
Renewi* (EBIT/EBITDA/EPS) |
127 |
139 |
252 |
265 |
78 |
85 |
Implied valuation (€m) |
1725 |
1532 |
1586 |
1512 |
||
Provisions (€m) |
(306) |
(306) |
(306) |
(306) |
||
Debt (€m) |
(406) |
(422) |
(406) |
(422) |
||
Finance leases (€m) |
(246) |
(246) |
(246) |
(246) |
||
Pension deficit (€m) |
(30) |
(30) |
(30) |
(30) |
||
Implied market cap (€m) |
736 |
528 |
598 |
509 |
||
Number of shares (m) |
80.5 |
80.7 |
80.5 |
80.7 |
||
Value per share (€c) |
915 |
655 |
742 |
630 |
1,349 |
1,203 |
Exchange rate (€/£) |
1.15 |
1.15 |
1.15 |
1.15 |
1.15 |
1.15 |
Value per share (p) |
795 |
569 |
646 |
548 |
1,173 |
1,046 |
Provision adjustment |
(331) |
(331) |
||||
Value per share (p) |
795 |
569 |
646 |
548 |
843 |
715 |
Source: Edison Investment Research. Note: *Renewi financials have been calendarised.
Exhibit 22: Financial summary
2021 |
2022 |
2023 |
2024e |
2025e |
|
Year to March (€m) |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
INCOME STATEMENT |
|||||
Revenue |
1,693.6 |
1,869.2 |
1,892.3 |
1,914.2 |
1,964.0 |
Cost of Sales |
(1,408.5) |
(1,512.5) |
(1,538.4) |
(1,554.4) |
(1,590.9) |
Gross Profit |
285.1 |
356.7 |
353.9 |
359.9 |
373.2 |
EBITDA |
202.2 |
261.5 |
257.0 |
250.0 |
270.4 |
Operating profit (before amort. and excepts.) |
73.0 |
133.6 |
132.9 |
124.8 |
144.0 |
Amortisation of acquired intangibles |
(3.3) |
(3.4) |
(5.0) |
(5.5) |
(6.0) |
Exceptionals |
(33.6) |
(6.2) |
(5.6) |
(5.0) |
0.0 |
Reported operating profit |
36.1 |
124.0 |
122.3 |
114.3 |
138.0 |
Net Interest |
(26.8) |
(28.8) |
(29.2) |
(38.9) |
(42.7) |
Joint ventures & associates (post tax) |
1.6 |
0.5 |
0.0 |
0.0 |
0.0 |
Profit Before Tax (norm) |
47.8 |
105.3 |
103.7 |
85.9 |
101.4 |
Profit Before Tax (reported) |
10.9 |
95.7 |
93.1 |
75.4 |
95.4 |
Reported tax |
(5.4) |
(20.3) |
(26.5) |
(18.8) |
(23.8) |
Profit After Tax (norm) |
35.8 |
78.8 |
75.6 |
62.7 |
74.0 |
Profit After Tax (reported) |
5.5 |
75.4 |
66.6 |
56.5 |
71.5 |
Minority interests |
(0.1) |
(0.9) |
(3.7) |
(2.5) |
(3.0) |
Net income (normalised) |
35.7 |
77.9 |
71.9 |
60.2 |
71.0 |
Net income (reported) |
5.4 |
74.5 |
62.9 |
54.0 |
68.5 |
Av. Shares outstanding (m) |
79.5 |
79.7 |
80.3 |
80.5 |
80.7 |
EPS - normalised (c) |
45 |
98 |
90 |
75 |
88 |
EPS - normalised fully diluted (c) |
45 |
98 |
89 |
74 |
87 |
EPS - basic reported (c) |
7 |
93 |
78 |
67 |
85 |
Dividend (c) |
0.0 |
0.0 |
0.0 |
5.0 |
10.0 |
Revenue growth (%) |
10.4 |
1.2 |
1.2 |
2.6 |
|
Gross Margin (%) |
16.8 |
19.1 |
18.7 |
18.8 |
19.0 |
EBITDA Margin (%) |
11.9 |
14.0 |
13.6 |
13.1 |
13.8 |
Normalised Operating Margin |
4.3 |
7.1 |
7.0 |
6.5 |
7.3 |
BALANCE SHEET |
|||||
Fixed Assets |
1,612.3 |
1,565.9 |
1,686.2 |
1,721.0 |
1,759.7 |
Intangible Assets |
594.9 |
592.8 |
636.3 |
630.8 |
625.3 |
Tangible and Right-of-use Assets |
794.5 |
767.4 |
871.0 |
911.3 |
955.5 |
Investments & other |
222.9 |
205.7 |
178.9 |
178.9 |
178.9 |
Current Assets |
355.7 |
385.9 |
399.3 |
388.6 |
400.2 |
Stocks |
20.6 |
22.5 |
25.2 |
27.2 |
27.9 |
Debtors |
247.7 |
269.3 |
289.6 |
279.6 |
290.5 |
Cash & cash equivalents |
68.8 |
63.6 |
62.7 |
60.0 |
60.0 |
Other |
18.6 |
30.5 |
21.8 |
21.8 |
21.8 |
Current Liabilities |
(646.7) |
(732.7) |
(665.4) |
(695.6) |
(706.4) |
Creditors |
(546.2) |
(528.4) |
(521.8) |
(518.8) |
(529.6) |
Tax and social security |
(13.8) |
(24.2) |
(31.2) |
(31.2) |
(31.2) |
Short term borrowings |
(47.8) |
(148.9) |
(66.8) |
(100.0) |
(100.0) |
Other |
(38.9) |
(31.2) |
(45.6) |
(45.6) |
(45.6) |
Long Term Liabilities |
(1,083.7) |
(880.9) |
(1,072.8) |
(1,007.6) |
(982.7) |
Long term borrowings |
(689.1) |
(518.7) |
(681.6) |
(681.4) |
(696.5) |
Other long term liabilities |
(394.6) |
(362.2) |
(391.2) |
(326.2) |
(286.2) |
Net Assets |
237.6 |
338.2 |
347.3 |
406.4 |
470.8 |
Minority interests |
(6.1) |
(7.0) |
(10.1) |
(10.1) |
(10.1) |
Shareholders' equity |
231.5 |
331.2 |
337.2 |
396.3 |
460.7 |
CASH FLOW |
|||||
Operating Cash Flow |
202.2 |
261.5 |
257.0 |
250.0 |
270.4 |
Working capital |
82.4 |
(59.9) |
(23.8) |
5.0 |
(0.8) |
Exceptional & other |
(31.1) |
(17.1) |
(23.6) |
(71.0) |
(41.0) |
Tax |
(14.8) |
(7.6) |
(21.2) |
(23.2) |
(27.4) |
Net operating cash flow |
238.7 |
176.9 |
188.4 |
160.8 |
201.2 |
Capex |
(57.6) |
(77.3) |
(118.1) |
(112.0) |
(120.0) |
Acquisitions/disposals |
(2.7) |
(3.2) |
(60.7) |
0.0 |
0.0 |
Net interest |
(15.9) |
(17.2) |
(21.3) |
(39.5) |
(43.3) |
Equity financing |
(1.2) |
(1.6) |
(4.7) |
0.0 |
0.0 |
Dividends |
0.0 |
0.0 |
0.0 |
0.0 |
(8.0) |
Net Cash Flow |
161.3 |
77.6 |
(16.4) |
9.3 |
29.9 |
Opening net debt/(cash) |
(456.9) |
(343.7) |
(303.1) |
(370.7) |
(406.4) |
FX |
(6.4) |
7.6 |
(0.2) |
0.0 |
0.0 |
Other non-cash movements |
(41.7) |
(44.6) |
(51.0) |
(45.0) |
(45.0) |
Closing net debt/(cash) |
(343.7) |
(303.1) |
(370.7) |
(406.4) |
(421.5) |
Finance Leases (FRS16) |
(236.7) |
(221.9) |
(245.8) |
(245.8) |
(245.8) |
PPP non-recourse |
(87.6) |
(79.1) |
(69.3) |
(69.3) |
(69.3) |
Closing net debt/(cash) |
(668.0) |
(604.1) |
(685.8) |
(721.5) |
(736.6) |
Source: Company accounts, Edison Investment Research
|
|
Research: Healthcare
SIGA recapped several key developments in its Q3 update, signalling strong top-line momentum going into Q423. Most notably, the recent $18m procurement deal with the European Health Emergency Preparedness and Response Authority (HERA) has surprised to the upside, with more value to be unlocked, in our opinion. With upcoming BARDA (oral and IV TPOXX), Department of Defense (DoD) and HERA deliveries, Q423 will likely be a busy quarter for SIGA. We have increased our FY23 product revenue estimates to c $164m ($155m previously) to reflect the HERA orders, although this has been offset by lower R&D revenue estimates ($8.9m vs $20.5m previously) following the receipt of the final payment under the PEP research contract with the DoD (in Q323). Management continues to target the PEP regulatory submission in 2024 (despite undertaking a trial data reanalysis) and we view this as a next significant milestone for SIGA. Incorporating the results and latest net cash figure, our valuation adjusts to $17.24/share ($17.46/share previously).